Comparison of Whole Blood Fibrin-Based Clot Tests in Thrombelastography and Thromboelastometry | Zendy

Cristina Solomon | Zendy; Benny Sørensen | Zendy; Gerald Hochleitner | Zendy; Jeffry L. Kashuk | Zendy; Marco Ranucci | Zendy; Herbert Schöchl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of Whole Blood Fibrin-Based Clot Tests in Thrombelastography and Thromboelastometry

Author(s) -

Cristina Solomon,

Benny Sørensen,

Gerald Hochleitner,

Jeffry L. Kashuk,

Marco Ranucci,

Herbert Schöchl

Publication year - 2012

Publication title -

anesthesia and analgesia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.404

H-Index - 201

eISSN - 1526-7598

pISSN - 0003-2999

DOI - 10.1213/ane.0b013e31824724c8

Subject(s) - thromboelastometry , thrombelastography , fibrin , medicine , hydroxyethyl starch , fibrinogen , clotting time , heparin , dilution , anesthesia , coagulation , immunology , physics , thermodynamics

Fibrin-based clot firmness is measured as maximum amplitude (MA) in the functional fibrinogen (FF) thrombelastographic assay and maximum clot firmness (MCF) in the FIBTEM thromboelastometric assay. Differences between the assays/devices may be clinically significant. Our objective was to compare clot firmness parameters through standard (FF on a thrombelastography device [TEG®]; FIBTEM on a thromboelastometry device [ROTEM®]) and crossover (FF on ROTEM®; FIBTEM on TEG®) analyses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research